Ann: Medigen Engages PharmaSynth to Manufacture P, page-3

re: Ann: Medigen Engages PharmaSynth to Manuf... They even bought a stake in Winston to add more production capacity...

http://www.taipeitimes.com/News/biz/archives/2013/11/11/2003576584

...but first production at progen was expected...

"Our investments must be strategic: for instance, we have to invest in Progen—the Australian company from whom we licensed PI-88—in order to ensure that they have the capacity to produce adequate quantities of API in the first two years after PI-88’s marketing approval. "

http://www.pharmaboardroom.com/article/interview-stanley-chang-chairman-and-ceo-medigen-biotechnology-corp